Skip to main content
Fig. 2 | BMC Geriatrics

Fig. 2

From: Cost-utility of medication withdrawal in older fallers: results from the improving medication prescribing to reduce risk of FALLs (IMPROveFALL) trial

Fig. 2

Prevalence of problems on the five dimensions of the EQ-5D in the control and intervention groups at baseline and 12 months follow-up. Nine and 23 participants in the control and intervention group declined or were unable to complete EQ-5D questionnaires after 12-months follow-up. *p-values were measured with the McNemar test

Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us